Tessy K. Paul, MD of the University of Virginia Health System discusses CTD's associated with ILD, diagnostic evaluation and management, interstitial pneumonia with autoimmune feature (IPAF), and new evidence with antifibrotics.
Social media platforms -
Twitter - @PFFORG
Facebook - @PFFORG
Instagram - @PFFORG
LinkedIn- Pulmonary Fibrosis Foundation
Please note that any information contained in this presentation is for informational and/or educational purposes only. It is not intended to be a substitute for professional medical advice. Always consult your personal physician or health care provider with any questions you may have regarding your specific medical condition.
This presentation is protected by U.S. and International copyright laws. Reproductions and distribution of this presentation without written permission from the Pulmonary Fibrosis Foundation is prohibited.
© 2020 Pulmonary Fibrosis Foundation
Негізгі бет What's New in CTD-ILDs? | Tessy K. Paul, MD
Пікірлер